Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of 460 patients with hepatocellular carcinoma (HCC)

From: Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma

Parameter RFA group (n = 159) MWA group (n = 301) P value
Sex    0.209
 Men 132 (83.0) 235 (78.1)  
 Women 27 (17.0) 66 (21.9)  
Age (years)a 54.0 ± 11.0 54.2 ± 11.0 0.889
 ≤65 138 (86.8) 255 (84.7) 0.549
 >65 21 (13.2) 46 (15.3)  
Heredity    0.461
 Yes 6 (3.8) 16 (5.3)  
 No 153 (96.2) 285 (94.7)  
Etiology    0.799
 Cryptogenic 21 (13.2) 38 (12.6)  
 HBV infection 128 (80.5) 250 (83.0)  
 HCV infection 8 (5.0) 11 (3.7)  
 Schistosomiasis 2 (1.3) 2 (0.7)  
Tumor size (cm)a 1.7 ± 0.3 1.7 ± 0.3 0.335
Tumor location    0.150
 Favorable 121 (76.1) 210 (69.8)  
 Unfavorable 38 (23.9) 91 (30.2)  
Child–Pugh class    0.127
 Class A 140 (88.1) 278 (92.4)  
 Class B 19 (11.9) 23 (7.6)  
HBV-DNAb    0.076
 Positive 70 (44.0) 107 (35.5)  
 Negative 58 (36.5) 143 (47.5)  
 Absent 31 (19.5) 51 (16.9)  
ALT (U/L)a 38.28 ± 23.22 38.37 ± 26.80 0.960
 <40 113 (71.1) 237 (78.7) 0.059
 40–80 36 (22.6) 57 (18.9)  
 >80 10 (6.3) 7 (2.4)  
TBIL (μmol/L)a 17.53 ± 8.33 17.51 ± 8.53 0.979
 ≤20 108 (67.9) 217 (72.1) 0.350
 >20 51 (32.1) 84 (27.9)  
DBIL (μmol/L)a 6.80 ± 3.91 7.33 ± 4.83 0.236
 ≤7 104 (65.4) 177 (58.8) 0.167
 >7 55 (34.6) 124 (41.2)  
ALB (g/L)a 40.60 ± 5.49 41.21 ± 5.31 0.243
 <35 25 (15.7) 38 (12.6) 0.358
 ≥35 134 (84.3) 263 (87.4)  
GGT (U/L)a 85.79 ± 83.51 77.98 ± 113.45 0.445
 <50 89 (56.0) 187 (62.1) 0.125
 50–100 38 (23.9) 75 (24.9)  
 >100 32 (20.1) 39 (13.0)  
PLT (×109/L)a 120.37 ± 55.13 122.60 ± 60.00 0.696
 <100 67 (42.1) 122 (40.5) 0.739
 ≥100 92 (57.9) 179 (59.5)  
PT (s)a 12.9 ± 1.3 12.9 ± 1.3 0.699
 ≤13 101 (63.5) 185 (61.5) 0.665
 >13 58 (36.5) 116 (38.5)  
AFP level (μg/L)    0.144
 <20 69 (43.4) 156 (51.8)  
 20–200 44 (27.7) 80 (26.6)  
 >200 46 (28.9) 65 (21.6)  
CA19-9 (kU/L)    0.053
 ≤39 107 (67.3) 228 (75.7)  
 >39 52 (32.7) 73 (24.3)  
Hospital stay (days)a 3.4 ± 1.7 3.4 ± 2.3 0.975
  1. RFA radiofrequency ablation, MWA microwave ablation, HBV hepatitis B virus, HCV hepatitis C virus, ALT alanine aminotransferase, TBIL total bilirubin, DBIL direct bilirubin, ALB albumin, GGT gamma-glutamyl transpeptidase, PLT platelet, PT prothrombin time, AFP alpha fetoprotein, CA19-9 carbohydrate antigen 19-9
  2. aThese data are presented as mean ± standard deviation; other values are presented as number of patients followed by percentage in parentheses
  3. bHBV-DNA level of more than 50 copies/mL is considered HBV-DNA positive